Physical Behavior Profiles in Chronic Cancer-Related Fatigue by Wolvers, M.D.J. (M. D.J.) et al.
Physical Behavior Profiles in Chronic Cancer-Related Fatigue
M. D. J. Wolvers1,2 & J. B. J. Bussmann3 & F. Z. Bruggeman-Everts2,4 & S. T. Boerema1,2 &
R. van de Schoot5,6 & M. M. R. Vollenbroek-Hutten1,2
Published online: 11 July 2017
# The Author(s) 2017. This article is an open access publication
Abstract
Purpose Increasing physical activity level is a generally ef-
fective intervention goal for patients who suffer from chronic
cancer-related fatigue (CCRF). However, patients are unlikely
to benefit equally from these interventions, as their behavioral
starting points might vary substantially. Therefore, we ex-
plored patterns of physical behavior of participants who suffer
from CCRF.
Methods Baseline data of a randomized controlled trial were
used for a latent profile analysis on nine accelerometer-
derived physical behavior measures, describing levels and
patterns of physical activity, moderate-to-vigorous intensity
physical activity (MVPA), and sedentary behavior. The
relation between participant characteristics and the latent pro-
files was analyzed.
Results Accelerometer data of 172 participants from the
Netherlands was analyzed. Three latent profiles were distin-
guished that differed most on physical activity level and total
time spent in MVPA. Eighty-eight percent of all participants
were assigned to a profile with a probability higher than 8.
Age and perceiving limitations by comorbid conditions and
pain were significant covariates of profile membership.
Conclusions We distinguished three physical behavior pro-
files. The differences between the patterns indicate that the
heterogeneity of this sample requires patients to have substan-
tially different treatment goals. Further research should test the
applicability of these profiles in clinical practice.
Keywords Cancer . Oncology . Latent profiles analysis .
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Introduction
Fatigue is a common and debilitating side effect of cancer and
its treatment that often persists well beyond active cancer
treatment [1, 2]. Chronic cancer-related fatigue (CCRF) pre-
vents patients to have Ba normal life^ [3] and hampers in
performing daily activities [4].
The role of physical activity in the context of chronic
cancer-related fatigue is neither straightforward nor evident.
For example, inactivity has been proposed as a result as well
as a cause of fatigue. Lower physical activity was associated
with fatigue before initiation of treatment [5] and with persis-
tence of fatigue [1]. However, a large cohort study of Neil
et al. [6] showed no difference in inactivity between cancer
survivors and individuals with no history of cancer, and
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another study showed that self-reported physical activity was
no predictor for fatigue before and after chemotherapy [7].
Behavioral interventions that try to reduce fatigue usu-
ally aim at increasing level of physical activity by means
of exercise or graded activity [8–11]. These interventions
are generally effective in reducing fatigue [8–12]. Such
interventions should be adapted to individual physiologi-
cal differences [13] to be fully appreciated. Presumably,
effective interventions correspondingly depend on the in-
dividual’s starting point in terms of physical behavior.
Therefore, it is needed to consider the heterogeneity of
patients’ physical behavior and to explore what patient
characteristics relate to these behaviors.
In fact, heterogeneity in physical behavior has been scarce-
ly considered in behavioral intervention studies. One example
is a study by Van der Werf et al. who aimed to reveal hetero-
geneity of physical behavior in non-cancer patients who suffer
from chronic fatigue syndrome [14]. Patients were labeled
pervasively passive, active, or moderately active based on
their total amounts of physical activity. Such Bsub-typing^
can help to personalize interventions and define helpful and
realistic treatment goals.
Other, more specific physical behavior measures than
total amounts of physical activity are increasingly ac-
knowledged as important and clinically relevant. Firstly,
benefits of exercising or performing higher intensity ac-
tivities are substantiated for cancer survivors [10].
Secondly, deteriorating effects of high amounts of seden-
tary behavior are increasingly acknowledged [15, 16] and
addressed in many guidelines for cancer survivors [13].
Thirdly, measures that quantify distributions of these be-
haviors over time [17–19] were able to differentiate pa-
tients with chronic health conditions comparable to CCRF
from healthy subjects independently of the total amounts
of these physical behaviors. Consequently, focusing solely
on total amounts of physical activity is probably too
generic.
To acknowledge the relevance of different measures of
physical behavior, Thompson et al. advocate to use profiles
to describe physical activity of individuals [20]. This inherent-
ly leads to the research question in the current paper: What
physical behavior profiles are prominent in persons who suffer
from CCRF? This paper explicitly focusses on the interrelat-
edness of a range of physical behavior measures, which is
novel in this field.
Secondly, this paper explores if the physical behavior pro-
files are related to participant characteristics. Therefore, demo-
graphic and clinical factors (age, sex, education, body mass
index (BMI), working hours, cancer treatment types, time
since last cancer treatment, and limitations due to pain or
comorbidities), as well as fatigue, distress, and perceived work




This study is a cross-sectional analysis of the baseline data of a
randomized controlled trial to study Internet interventions for
CCRF (approved by the Twente Medical Ethical Committee,
Enschede, the Netherlands under number P12–26 and regis-
tered at The Netherlands National Trial Register (NTR3483,
http://www.webcitation.org/6NWZqon3o)). Baseline data
was assessed online on two occasions: during the
registration process (T0a) and after eligibility was confirmed
(T0b). At T0b, participants were asked to wear a hip-worn
accelerometer for seven consecutive days, during waking
hours, starting on a Friday and to keep activity diaries for
the periods that they did not wear the accelerometer.
Extensive information about the trial design is provided else-
where [21].
Participants
Of 179 patients who started the FNK-trial, seven did not
provide sufficient accelerometer data, leaving 172 partic-
ipants for the analyses (see Supplementary Materials, F1,
for a flow chart). Participants were mostly women (72%),
on average 56 years of age (between 21 and 82). Fifty-
three percent of the participants acquired a college degree
or higher. Most participants had breast cancer (46%) or
hematological malignancies (17%). 9.4% had experienced
recurrence of cancer, and 14% had metastasized cancer.




Accelerometer Data Preprocessing We focused on three
dimensions of physical behavior: overall levels of physi-
cal activity, sedentary behavior (SB), and moderate-to-
vigorous intensity physical activity (MVPA). These di-
mensions were operationalized as total amount measures,
bout duration measures, and day part distribution mea-
sures. An overview is presented in the Supplementary
Materials (T1).
The accelerometer (ProMove 3D, Inertia Technology,
Enschede, the Netherlands, well described elsewhere
[20]) outputs Bintegral of the modulus of acceleration^
per minute in metric units (10−3 m/s2), which in this paper
is referred to as counts per minute (cpm). The accelerom-
eter data were scanned and processed in Matlab version
R2013b (The MathWorks Inc., Boston, MA, USA). Non-
wear was removed only when agreement was reached
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between two researchers (no agreement was reached in
<1% of all measurement days). Reasons for missing accel-
erometer data were diverse (forgetting to charge or wear
the system, esthetic objections, performing non-
accelerometer-compatible activities such as swimming or
sleeping, and various technical failures) but, unfortunately,
sparsely provided in the activity diaries.
A measurement day was considered valid if it is
consisted of >600 min of data. Three-day parts were
distinguished: morning (05 h00 to 12 h00), afternoon
(12 h00 to 18 h00), and evening (18 h00 to 00 h00). Day
parts were considered valid if they are consisted of
>120 min of data. An average of at least four valid days
or day part combinations was required for analysis.
Amount Measures Physical activity level (PAL (cpm)) was
calculated by averaging all cpm values per day [22]. SB time
(%) was the percentage of the total measurement time spent
below 1303 cpm. Ninety-five percent of the distribution of SB
in a lab study was captured below this value [23]. One thou-
sand three hundred and three counts per minute is well below
walking at a comfortable speed (z = −1.97) [20] and
performing active office tasks (z = −2.58) [23]. MVPA time
(%) was the percentage of the total measurement time spent
above 2588 cpm. Two thousand five hundred eighty-eight
counts per minute is the right limit of the 95% confidence
in terva l of t readmil l walking at 6 km per hour
(2418 ± 275 cpm, n = 10) [24]. Two thousand five hundred
eighty-eight counts per minute corresponds with a z-score of
0.36 of walking at a comfortable speed and a z-score of −0.32
of active office tasks.
Bout Duration Measures Time of prolonged SB bouts (min)
was the total SB time that was accumulated in bouts of 30 min
and longer [25]. Time of prolonged MVPA bouts (min) was
the total MVPA time that was accumulated in bouts of 10 min
and longer [25].
Day Part Distribution Measures For the day part difference
of PAL (dPAL), the change score of the average PALs of two
consecutive day parts was divided by the average PAL of the
afternoon to correct for absolute difference of daily PALs be-
tween participants:
dPAL1 = (PAL afternoon − PAL morning)/ PAL afternoon
dPAL2 = (PAL evening – PAL afternoon)/ PAL afternoon
For the day part difference of SB time (dSB), change scores
between two consecutive day parts were calculated from the
fractions (F) of the time of each day part that was spent
sedentary:
dSB1 = Fafternoon – Fmorning
dSB2 = Fevening – Fafternoon
Covariates
Fifteen factors were studied as covariates of the latent
profiles, among which age, sex, BMI (calculated from
self-reported height and weight), education (seven an-
swers possible, dichotomized as accomplished college de-
gree or higher), weeks since last primary cancer treatment
(log transformed to account for skewness), and work sta-
tus (dichotomized as working more than 8 h per week).
Cancer treatments were categorized as chemotherapy, ra-
diotherapy, and/or stem cell transplant. Comorbid condi-
tions were categorized as (1) lung, (2) cardiovascular, (3)
musculoskeletal, (4) neurologic, and (5) organ disease, (6)
back and neck pain and trauma(tic) injuries, and (7)
Bother comorbidities^ (mainly sleep apnea), and counted.
Limitations by comorbid conditions were assessed: BHow
limiting are these complaints or disease(s) currently for
you?^ Answers ranged from not at all (1) to very limiting
(4) and were dichotomized by a cutoff score ≥ 3.
Limitations by pain were assessed: BIn the past week, to
what extend did you feel limited in performing daily
physical activities because of pain?^ Answers ranged
from not at all limited (1) to extremely limited (7) and
were dichotomized by a cutoff score ≥ 4.
Fatigue was assessed at T0b (Cronbach’s α = 0.839,
N = 170) with the subscale fatigue severity of the
Checklist Individual Strength [26, 27]. The sum score has
been used in cancer survivors [1, 28] and has shown good
internal consistency and discriminative validity [29].
Distress was assessed at T0a (Cronbach’s α = 0.883,
N = 172) with the Hospital Anxiety and Depression
Scale. The sum score has been validated thoroughly [30]
and has been used in cancer survivor populations [31–34].
Perceived work-ability was assessed at T0b with the work
ability index [35]: one question BImagine that your work-
ing ability in the best period of your life is rated 10 points.
How would you rate your working ability at the present
moment?^ that is answered on a scale from 0 (Bnot being
able to work at all^) to 10.
Missing Covariate Data The variables BMI and weeks since
last treatment had missing values: 18 and 1 observations were
missing, respectively. Furthermore, one participant did not
finish the T0b assessment. Between samples t tests and chi-
square tests revealed that participants with missing BMI’s re-
ported lower perceived work ability (95% confidence interval
of the difference (−1.694–0.001)), but were comparable on the
other predictor variables.
Statistical Analyses
The primary research question was answered with latent pro-
file analysis with robust—full information—maximum log
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likelihood estimation in Mplus version 7.4 (Muthén and
Muthén, Los Angeles, CA, USA). Indicators were z-scores
of the physical behavior measures.
Model Checking
Three model series (models Ak, Bk, Ck) were compared to
decide how to deal best with theoretical pre-established
overlap among the indicators (PAL with SB, pSB,
MVPA, and pMVPA; MVPA with pMVPA; SB with pSB;
dPAL1 with dSB1; and dPAL2 with dSB2), while ac-
knowledging the distribution of pMVPA (left-skewed, 35
zero-observations). In each series, an ascending number of
profiles was imposed (K = 2–5). In models Ak, pMVPA
was modeled as a left-censored variable, thus covariances
with pMVPAwere ignored. In models Bk, pMVPAwas log
transformed. In models Ck, overlap between the indicator
variables was captured in four latent factors. The
Supplementary Materials provide diagrams (F2) and
Mplus syntax (T2) for all three model series.
Latent Profiles Analysis
The results of the final model series were reported with
Bayesian information criteria (BIC), class proportions, entro-
py, bootstrapped likelihood ratio tests, and Lo-Mendel-Rubin
likelihood ratio tests. The best model from this series was
established by evaluating the BIC [36] and reported by the
profile means, standard deviations, and posterior probabilities
for each profile.
Covariates
The relation between the physical behavior profiles and par-
ticipant characteristics was explored by means of Vermunt’s
three-step approach [37], currently only available with list-
wise deletion. The factor Bstem cell transplant^ had only one
observation in one profile, and therefore was omitted. A
backward elimination strategy was used. In each step, the
factor with the highest p value of all lowest p values per factor
was removed until only factors with a lowest p value below




Not all models converged convincingly. Models A4 and
A5 had no stable solutions, even when running 200.000
starts, and resulted in multiple errors and small profiles.
Only one model (B2) from the B series and none from
the C series resulted in stable solutions. The log trans-
formation was not sufficient to specify pMVPA correctly
in models Bk, and models Ck were too complex for the
amount of data. Therefore, we proceeded with the model
Ak series, which converged adequately up to three
classes.
Latent Profiles Analysis
The results for the model Ak series are presented in
Table 1. Model A3 was selected because that model had a
lower BIC than the two-profile model. The A3 model re-
sulted in profiles of 28, 71, and 73 participants in each
profile, and most participants were allocated convincingly;
88% of the participants were allocated to a profile with
probability higher than 0.8.
The profile means for model A3 (and for completeness also
A2), standardized to z-scores of the total sample, are shown in
Fig. 1. Raw profile means, standard deviations, and posterior
probabilities are presented in Table 2. To improve readability,
the A3 profiles are labeled Bactive^, Baverage^, and
Bsedentary .^
Table 1 Model results of the Ak





1 3435.299 Not applicable Not applicable Not applicable 172
2 3269.204 0.804 261.23 (.02) <.001 72; 100
3 3218.251 0.848 147.25 (.23) <.001 28; 71; 73
4a Not available 0.869 Not performed Not performed 7; 49; 55; 61
5a Not available 0.901 Not performed Not performed 4; 19; 40; 46; 63
K number of imposed profiles, BIC Bayesian information criterion, LMR Lo-Mendel-Rubin likelihood ratio test,
BLRT bootstrapped likelihood ratio test
a No stable models were estimated; the models with best log likelihoods after 200,000 random starts are reported
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The right panel of Fig. 1 shows that the mean scores of the
average profile are similar to the samplemean scores (z < |0.5|)
for all indicators. The sedentary and active profile can be
distinguished best from the average profile by PAL and
MVPA. However, differences between profiles are also cap-
tured in the mean scores of other measures. For example,
decline of physical activity from morning to afternoon was
lowest (so high dPAL1) in the average profile. By contrast,
dPAL2 was not distinctive at all. The Supplementary
Materials (F3) show histograms of the sample profile
distributions, which provide further insight into the distinctive
character of all indicator measures.
Covariates
Exploration of the relation between the physical behavior pro-
files and participant characteristics showed that participants in
the sedentary profile were older and less likely to report lim-
itations by comorbid conditions compared to the average pro-
file and were more likely to have limitations by pain compared
Fig. 1 Standardized profile
means (z-scores) of models A2
(left) and A3 (right). SB, dSB1,
and dSB2 have switched signs,
thus are defined “higher is better.”
PAL physical activity level,MVPA
moderate-to-vigorous intensity
physical activity time, pMVPA
prolonged bouts of MVPA, SB
sedentary behavior time, pSB
prolonged bouts of SB, dPAL and
dSB (day part difference: 1
morning to afternoon, 2 afternoon
to evening)
Table 2 Model results of the A3 model
Total samplec Sedentary Average Active
N (%) 71 (41%) 73 (42%) 28 (16%)
Profile posterior probabilitiesb, mean (lowest) 0.936 0.926 (.50) 0.944 (.59) 0.943 (.66)
Profile posterior probabilities <0.8, N (%) 20 (12%) 11 (15%) 7 (10%) 2 (7%)
mean stdev mean stdev mean stdev mean stdev
Physical activity level (cpm) (N = 165) 790.3 217.0 609.7 71.0 834.1 43.6 1081.5 103.7
MVPA (%) (N = 165) 6.22 3.47 0.10 0.62 13.06 1.38 27.94 2.43
Prolonged bouts of MVPA (min) (N = 165)a 10.64 a 12.62 3.14 5.36 8.87 8.77 24.82 28.35
Sedentary behavior time (%) (N = 165) 78.36 7.21 84.84 2.09 76.02 2.39 69.85 4.18
Prolonged bouts of SB (min) (N = 165) 325.6 110.6 391.3 88.7 295.8 84.7 254.5 56.8
dPAL1 (%-pt) (N = 148) −17.47 35.07 −28.83 41.70 −3.72 17.7 −27.15 30.5
dPAL2 (%-pt) (N = 166) −28.80 22.49 −28.21 26.36 30.30 20.0 −26.32 21.60
dSB1 (%-pt) (N = 148) 2.1 8.4 2.8 5.0 0.1 9.4 5.7 10.1
dSB2 (%-pt) (N = 166) 10.2 7.1 7.5 4.38 11.8 6.7 12.3 8.3
stdev standard deviation, MVPA moderate-to-vigorous intensity physical activity time, dPAL and dSB day part difference (1: morning to afternoon, 2:
afternoon to evening)
a Skewness = 2.13; kurtosis = 6.66; median = 6.57. 15% of the total sample (n = 25) accrued >21 min of pMVPA per day, thus potentially accrues
150 min of pMVPA per week.
b The profile mean (of those participants who were actually assigned to this specific profile) of the posterior probabilities for each profile. Between
brackets is the lowest posterior probability with which a participant was assigned to that profile
c Supplementary Materials (T4) shows the bivariate covariances matrix and modeled covariances on the overall level of models A1 and A3
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to participants in the active profile. The results are presented in
Table 3.
Discussion
In this study, multiple physical behavior measures were col-
lected to exhibit heterogeneity of patients who suffer from
CCRF by means of physical behavior profiles. Three profiles
were distinguished: a sedentary, active, and average profile.
Furthermore, we investigated participant characteristics as co-
variates of these profiles, to increase knowledge on and en-
hance personalization of interventions that somehow target
physical behavior in this population.
The three profiles were mostly distinguished by the mea-
sures PAL and MVPA time. Compared to the sedentary pro-
file, participants in the active profile were roughly twice as
active in terms of PAL and spent almost seven times longer on
prolonged MVPA. Time spent in prolonged bouts of SB also
differed between profiles: means were 4 h and 15 min in the
active profile, compared to 6 h and 31 min in the sedentary
profile. The average profile had the lowest (almost no) decline
of PAL between morning and afternoon. These results show
that persons who suffer from CCRF form a very heteroge-
neous group in terms of physical behaviors, who require di-
verse intervention goals when focusing on physical behavior.
All three profiles provide potential focus for intervening on
physical behavior in clinical practice. Obvious goals—and
currently widely accepted [13]—are increasing PAL and
prolonged MVPA time, which apply to participants in the
sedentary and average profile. However, in the active profile,
increasing PAL is expected to be less effective compared to
the other profiles. Patients who have an active profile might
benefit from reducing the time of pronged SB or from better
dividing physical activities throughout the day by energy con-
servation strategies [38]. Indeed, a patient in the active profile
may actually be helped by reducing PAL before increasing it
gradually in order to match the patient’s physical behavior to
his or her capacity. This assumption is supported by a study in
breast cancer survivors in which self-reported physical activ-
ity measures showed that psychological outcomes were poor
for the quartile of patients with the highest durations of phys-
ical activity [39].
Boundaries between the physical behavior profiles are not
strict, which hampers direct transfer to clinical practice; 88%
of the participants were assigned to a profile with a probability
above 80%. The distinct profiles can provide a direction for
defining an effective physical behavior goal, but encourage to
match the intervention goals to the patient’s perspective and
individual wishes as well.
The second research question focused on covariates of
these physical behavior profiles. Participants who reported
Table 3 Predictive value of participant characteristics of the three-profile model









Age (years) 55.8 (10.2) −0.070 (.001) −.047 (.105) −0.024 (.372)
Sex (male) 28% 2 (.698)
Education (≥ college degree) 52.9% 3 (.581)
Work status (> 8 h/week) 53.8% 6 (.423)
Body mass index (kg/m2) (N = 154) 26.4 (5.1) 9 (.061)
Weeks since last treatmentb 206 (236) 7 (.248)
Comorbid conditions (≥ 2) 14.0% 4 (.465)
Limitations by comorbid condition (≥ 3/4) 37.8% 1.496 (.002) 1.48 (.011) 0.015 (.977)
Limitations by pain (≥ 4/7) 32.8% −0.923 (.046) −1.959 (.006) 1.035 (.136)
Treatment: chemo 69.6% 8 (.27)
Treatment: radiotherapy 59.7% 1 (.717)
Treatment: stem cell transplant 6.4% 0c
Fatigue (8–56) 42.0 (8.0) 11 (.010)
Distress (0–42) 14.3 (6.8) 5 (.474)
Work ability (0–10) 3.2 (1.7) 10 (.035)
a Values are reported as logodds (p value). Logodds > 0 indicate that the risk of the outcome falling in the comparison profile relative to the risk of the
outcome falling in the referent profile increases as the variable increases. Univariate results are presented in the Supplementary Materials (T5)
bMedian: 126 weeks
c In the active profile, only one participant had experienced a stem cell transplant; therefore, this factor was excluded from the analyses
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stronger limitations by pain were more likely to have a seden-
tary profile compared to an active profile. This result high-
lights the relevance of pain management in the context of
physical activity interventions as it could be a barrier for be-
coming more physically active and for staying physically ac-
tive when professional guidance in the context of rehabilita-
tion stops.
Additionally, older participants and participants who
reported no or only weak limitations due to comorbid
conditions were more likely to have a sedentary profile
compared to an average profile. Studies on—not necessar-
ily fatigued—breast cancer survivors support the results
on the associations with age [40]. The result on the asso-
ciation with limitations by comorbid conditions seems
contradictory to the findings on limitations by pain. An
explanation might be that comorbid conditions are per-
ceived as less limiting for those who are engaged in a
sedentary lifestyle, although it should be noted that the
question that assesses limitations due to comorbid condi-
tions do not explicitly mention physical activities.
Our sample is comparable to a sample of long-term
colon cancer survivors [25], in terms of prolonged
MVPA. Fourteen percent compared to 15% in the current
sample meets clinical guidelines, operationalized as
spending 150 min per week on MVPA in bouts of
10 min or longer. However, MVPA time (6.2%) differed
greatly from samples of breast cancer survivors: 1.9%
[16] and 1.1% [15]. Also, SB time (78.4% in our sample)
differed from breast cancer survivors (61.3% [41], 66.3%
[15], and 78.2% [16]) and from colon cancer survivors
(60.7% [25]). Prolonged SB differed even more:
152.9 min of prolonged SB [25] versus 325.6 min in the
current sample. Differences could relate to choices for
cutoff values, as well as to clinical status; the comparison
samples were not necessarily fatigued and homogeneous
groups in terms of cancer diagnoses.
Our study has a number of limitations. Firstly, all par-
ticipants were willing to follow an intervention in a trial
called BFitter after cancer^ and were aware that physical
activity was measured. Both properties could provide bias
by overestimating PAL compared to the general popula-
tion of CCRF. Secondly, generalizability might be ham-
pered because our sample was diagnosed with various
cancer types and received different treatments. Thirdly,
evaluating 1-minute measurement intervals, although gen-
erally used [42], causes real life data points to represent a
mixture of behaviors. Therefore, absolute values of SB
and MVPA measures should be interpreted cautiously.
Finally, in order to come to the set of physical behavior
measures, some measures and cutoff values for time or
cpm lack evidence or were chosen arbitrarily. However,
by describing these choices transparently, we presume that
the results of this study are valuable nevertheless.
Conclusions
Three profiles of physical behavior were distinguished in a
sample of severely fatigued cancer survivors, showing the
heterogeneous character of the sample. The results indicate
that optimal support might require substantially different treat-
ment goals for different patients. These profiles demonstrate
an opportunity for personalizing physical behavior oriented
treatment goals, but further research should test the applica-
bility of these profiles in clinical practice.
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